Biomaterials, Medical Devices and Pharmaceutical Sciences
RCSI researchers are using new biomaterials and novel processes to develop medical devices and other healthcare technologies which will be used to treat a variety of injuries and diseases.
Our impact
Neuroscience and psychiatric research at RCSI encompasses the full spectrum of research, with an emphasis on disorders such as epilepsy and stroke, neurodegenerative diseases including amyotrophic lateral sclerosis, and psychiatric diseases such as schizophrenia and bipolar disorder.
Read our impact stories
Pioneering research
Building on world-leading pre-clinical and clinical research into epilepsy and motor neurone disease, RCSI leads the SFI research centre FutureNeuro. It aims to improve the diagnosis, monitoring and treatment of chronic and rare neurological diseases that affect 700,000 people in Ireland and to to advance our understanding of how the brain works.
Our expertise
Testimonial
"Being part of a small, collaborative health science focussed research institute has been vital for my research programme to develop new materials to repair diseased and damaged tissues.”
“Research from our lab has shown that nanoparticles have real potential to be a game changer in the delivery of gene therapies.”
“Our group are developing a technology that will provide a safe and reparative treatment strategy for patients suffering from osteoporotic vertebral fractures, a common and debilitating condition. We hope to restore the structural and mechanical health to the spine, allowing patients to live a normal and healthy life”
Progressive collaborations
RCSI plays a key role in a number of national and international neurological and psychiatric research centres and collaborates with international academic institutions and industry partners.